title: Advances in the medical research and clinical applications on the plasma DNA.
abstract: Plasma DNA has had a strong impact and influence on basic medical research and clinical practice since the discovery of low levels of plasma DNA in healthy individuals under different physiological conditions. Although the source of circulating DNA still requires further investigation, a wide range of research has also proven the value of qualitative and quantitative measurements of plasma DNA in many disease conditions. The use of plasma DNA has a biomarker is advantageous due to accessibility, reliability, reproducibility, sensitivity, specific and relatively low cost. Recently, the detection of circulating (plasma) DNA quantitative changes have been using in the studies on the tumor gene mutations and to monitor disease progressing and to predict the disease prognosis. Such technique also has been using other many different fields, particularly in prenatal diagnosis, for which plasma DNA testing is preferable due to non-invasiveness. This article reviews the research progression and clinical applications of plasma DNA in the last several years.
authors.affiliation: 1 Department of Hematology, The first Affiliated Hospital of Harbin Medical University, Harbin 150001, China ; 2 Western Sydney Genomic Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, NSW, Australia.
authors.forename: Shuye
authors.initials: S
authors.lastname: Wang
authors.affiliation: 1 Department of Hematology, The first Affiliated Hospital of Harbin Medical University, Harbin 150001, China ; 2 Western Sydney Genomic Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, NSW, Australia.
authors.forename: Yuanyuan
authors.initials: Y
authors.lastname: Chen
authors.affiliation: 1 Department of Hematology, The first Affiliated Hospital of Harbin Medical University, Harbin 150001, China ; 2 Western Sydney Genomic Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, NSW, Australia.
authors.forename: Zhanhe
authors.initials: Z
authors.lastname: Wu
keywords: Plasma DNA; haematological malignancies; non-invasive tool at diagnosis
references.citation: Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Feb;20(1):53-6
references.pmid: 22391164
references.citation: Clin Chem. 2008 Sep;54(9):1528-36
references.pmid: 18653827
references.citation: Neoplasma. 2010;57(6):507-11
references.pmid: 20845988
references.citation: Ann Oncol. 2009 Aug;20(8):1408-13
references.pmid: 19465421
references.citation: Clin Rheumatol. 2009 Dec;28(12):1437-40
references.pmid: 19669854
references.citation: Cancer Res. 2006 Aug 15;66(16):8309-17
references.pmid: 16912213
references.citation: Oncotarget. 2011 Mar;2(3):178-85
references.pmid: 21399237
references.citation: Clin Cancer Res. 2006 Jan 15;12(2):460-4
references.pmid: 16428487
references.citation: Cancer Res. 2003 May 1;63(9):2028-32
references.pmid: 12727814
references.citation: Eur J Surg Oncol. 2006 Nov;32(9):954-60
references.pmid: 16584865
references.citation: Br J Cancer. 2011 Feb 15;104(4):719-25
references.pmid: 21245866
references.citation: Clin Chem. 2005 Aug;51(8):1544-6
references.pmid: 16040855
references.citation: Breast Cancer Res. 2009;11(5):R71
references.pmid: 19772563
references.citation: J Cancer. 2013 Apr 16;4(4):323-9
references.pmid: 23678368
references.citation: Sao Paulo Med J. 2006 May 4;124(3):154-7
references.pmid: 17119693
references.citation: Clin Chem. 2003 Aug;49(8):1286-91
references.pmid: 12881444
references.citation: Yi Chuan. 2008 Jul;30(7):815-20
references.pmid: 18779122
references.citation: Int J Cancer. 2003 Jan 10;103(2):149-52
references.pmid: 12455027
references.citation: Blood. 2011 May 5;117(18):4860-2
references.pmid: 21389324
references.citation: J Clin Oncol. 2006 Sep 10;24(26):4262-9
references.pmid: 16908936
references.citation: Int J Cancer. 2008 Jan 1;122(1):138-43
references.pmid: 17764114
references.citation: Fetal Diagn Ther. 2009;26(1):24-8
references.pmid: 19816026
references.citation: Burns. 2008 Sep;34(6):809-16
references.pmid: 18243564
references.citation: Chin Med J (Engl). 2007 Jul 20;120(14):1256-9
references.pmid: 17697578
references.citation: Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):258-62
references.pmid: 18843981
references.citation: Lancet. 1997 Aug 16;350(9076):485-7
references.pmid: 9274585
references.citation: Clin Chem. 2008 Jun;54(6):1000-7
references.pmid: 18420731
references.citation: Clin Cancer Res. 2002 Jan;8(1):29-34
references.pmid: 11801537
references.citation: Blood. 2004 Apr 1;103(7):2799-801
references.pmid: 14576069
references.citation: Cancer Res. 1977 Mar;37(3):646-50
references.pmid: 837366
references.citation: Clin Chem. 2006 Sep;52(9):1820-4
references.pmid: 16840584
references.citation: Ann N Y Acad Sci. 2008 Aug;1137:226-31
references.pmid: 18837952
references.citation: Cancer Res. 1999 Jul 1;59(13):3251-6
references.pmid: 10397273
references.citation: Cancer Res. 1999 Jan 1;59(1):67-70
references.pmid: 9892187
references.citation: Ann Hematol. 2007 Feb;86(2):139-43
references.pmid: 17024502
references.citation: Cancer Lett. 2009 Mar 18;275(2):234-9
references.pmid: 19046801
references.citation: Bull Tokyo Dent Coll. 2008 May;49(2):77-87
references.pmid: 18776719